Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy
出版年份 2018 全文链接
标题
Targeting prostate cancer: Prostate-specific membrane antigen based diagnosis and therapy
作者
关键词
-
出版物
MEDICINAL RESEARCH REVIEWS
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-05-17
DOI
10.1002/med.21508
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Targeting PSMA by radioligands in non-prostate disease—current status and future perspectives
- (2018) Philipp Backhaus et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives
- (2018) Kamil Wdowiak et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Comprehensive Evaluation of Prostate Specific Membrane Antigen Expression in the Vasculature of Renal Tumors: Implications for Imaging Studies and Prognostic Role
- (2018) Sophia Spatz et al. JOURNAL OF UROLOGY
- Third-line treatment and 177Lu-PSMA radioligand therapy of metastatic castration-resistant prostate cancer: a systematic review
- (2017) Finn Edler von Eyben et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
- (2017) Philip Cornford et al. EUROPEAN UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer
- (2017) James M. Kelly et al. JOURNAL OF NUCLEAR MEDICINE
- Phase 2 Study of 99m Tc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN Dissection
- (2017) Karolien E. Goffin et al. JOURNAL OF NUCLEAR MEDICINE
- A PSMA-targeted theranostic agent for photodynamic therapy
- (2017) Ying Chen et al. JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
- Clinical translation of a PSMA inhibitor for 99m Tc-based SPECT
- (2017) Guillermina Ferro-Flores et al. NUCLEAR MEDICINE AND BIOLOGY
- 99m Tc-labeling and evaluation of a HYNIC modified small-molecular inhibitor of prostate-specific membrane antigen
- (2017) Xiaoping Xu et al. NUCLEAR MEDICINE AND BIOLOGY
- PSMA-Targeted Theranostic Nanocarrier for Prostate Cancer
- (2017) Orielyz Flores et al. Theranostics
- Anti-tumor effects of a recombinant anti-prostate specific membrane antigen immunotoxin against prostate cancer cells
- (2017) Ping Meng et al. BMC Urology
- 44Sc-PSMA-617 for radiotheragnostics in tandem with 177Lu-PSMA-617—preclinical investigations in comparison with 68Ga-PSMA-11 and 68Ga-PSMA-617
- (2017) Christoph A. Umbricht et al. EJNMMI Research
- [18F]Fluoroethyl Triazole Substituted PSMA Inhibitor Exhibiting Rapid Normal Organ Clearance
- (2016) Ying Chen et al. BIOCONJUGATE CHEMISTRY
- Development of 99mTc-labeled asymmetric urea derivatives that target prostate-specific membrane antigen for single-photon emission computed tomography imaging
- (2016) Hiroyuki Kimura et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Value of 111 In-prostate-specific membrane antigen (PSMA)-radioguided surgery for salvage lymphadenectomy in recurrent prostate cancer: correlation with histopathology and clinical follow-up
- (2016) Isabel Rauscher et al. BJU INTERNATIONAL
- 64Cu-PSMA-617 PET/CT Imaging of Prostate Adenocarcinoma: First In-Human Studies
- (2016) Bernhard Grubmüller et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer
- (2016) Kambiz Rahbar et al. CLINICAL NUCLEAR MEDICINE
- PSMA Expression in Papillary Thyroid Carcinoma
- (2016) Sameer Kamalakar Taywade et al. CLINICAL NUCLEAR MEDICINE
- Design, synthesis and biological evaluation of PSMA/hepsin-targeted heterobivalent ligands
- (2016) Milan Subedi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and pre-clinical evaluation of a new class of high-affinity 18F-labeled PSMA ligands for detection of prostate cancer by PET imaging
- (2016) James Kelly et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 18F-Labelled PSMA-1007 shows similarity in structure, biodistribution and tumour uptake to the theragnostic compound PSMA-617
- (2016) Frederik L. Giesel et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Synthesis and preclinical evaluation of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand
- (2016) Stefano Boschi et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
- (2016) Marlon Perera et al. EUROPEAN UROLOGY
- Linker Modification Strategies To Control the Prostate-Specific Membrane Antigen (PSMA)-Targeting and Pharmacokinetic Properties of DOTA-Conjugated PSMA Inhibitors
- (2016) Martina Benešová et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Biologic Evaluation of Novel 18F-Labeled Probes Targeting Prostate-Specific Membrane Antigen for PET of Prostate Cancer
- (2016) N. Harada et al. JOURNAL OF NUCLEAR MEDICINE
- (2S)-2-(3-(1-Carboxy-5-(4-211At-Astatobenzamido)Pentyl)Ureido)-Pentanedioic Acid for PSMA-Targeted -Particle Radiopharmaceutical Therapy
- (2016) A. P. Kiess et al. JOURNAL OF NUCLEAR MEDICINE
- PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617
- (2016) C. Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Evaluation of 18 F-PSMA-1007, a New Prostate-Specific Membrane Antigen Ligand for Prostate Cancer Imaging
- (2016) Jens Cardinale et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Evaluation and First Patient Application of 99m Tc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer
- (2016) Stephanie Robu et al. JOURNAL OF NUCLEAR MEDICINE
- 225Ac-PSMA-617 for PSMA-Targeted -Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer
- (2016) C. Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Theranostic Agents for Photodynamic Therapy of Prostate Cancer by Targeting Prostate-Specific Membrane Antigen
- (2016) X. Wang et al. MOLECULAR CANCER THERAPEUTICS
- PSMA-Based [18F]DCFPyL PET/CT Is Superior to Conventional Imaging for Lesion Detection in Patients with Metastatic Prostate Cancer
- (2016) Steven P. Rowe et al. MOLECULAR IMAGING AND BIOLOGY
- Lacrimal Glands May Represent Organs at Risk for Radionuclide Therapy of Prostate Cancer with [177Lu]DKFZ-PSMA-617
- (2016) Melanie Hohberg et al. MOLECULAR IMAGING AND BIOLOGY
- Clinical translation of 177Lu-labeled PSMA-617: Initial experience in prostate cancer patients
- (2016) Tapas Das et al. NUCLEAR MEDICINE AND BIOLOGY
- Radiolabeled enzyme inhibitors and binding agents targeting PSMA: Effective theranostic tools for imaging and therapy of prostate cancer
- (2016) Maroor Raghavan Ambikalmajan Pillai et al. NUCLEAR MEDICINE AND BIOLOGY
- Improved Synthesis andIn VitroEvaluation of an Aptamer Ribosomal Toxin Conjugate
- (2016) Linsley Kelly et al. Nucleic Acid Therapeutics
- In vitro and in vivo effects of a recombinant anti-PSMA immunotoxin in combination with docetaxel against prostate cancer
- (2016) Marta Michalska et al. Oncotarget
- Therapeutic response and side effects of repeated radioligand therapy with 177Lu-PSMA-DKFZ-617 of castrate-resistant metastatic prostate cancer
- (2016) Hojjat Ahmadzadehfar et al. Oncotarget
- Design of Internalizing PSMA-specific Glu-ureido-based Radiotherapeuticals
- (2016) Till Wüstemann et al. Theranostics
- Cancer of the prostate: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) C. Parker et al. ANNALS OF ONCOLOGY
- Synthesis and evaluation of constrained phosphoramidate inhibitors of prostate-specific membrane antigen
- (2015) Corinne R. Ley et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy
- (2015) Peter F. Mulders et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- A Phase I/II Study for Analytic Validation of 89Zr-J591 ImmunoPET as a Molecular Imaging Agent for Metastatic Prostate Cancer
- (2015) N. Pandit-Taskar et al. CLINICAL CANCER RESEARCH
- Detection of Brain Metastasis With 68Ga-Labeled PSMA Ligand PET/CT
- (2015) Partha Sarathi Chakraborty et al. CLINICAL NUCLEAR MEDICINE
- Pre-therapeutic dosimetry of normal organs and tissues of 177Lu-PSMA-617 prostate-specific membrane antigen (PSMA) inhibitor in patients with castration-resistant prostate cancer
- (2015) Levent Kabasakal et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Dosimetry for 177Lu-DKFZ-PSMA-617: a new radiopharmaceutical for the treatment of metastatic prostate cancer
- (2015) Andreas Delker et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PMPA for Nephroprotection in PSMA-Targeted Radionuclide Therapy of Prostate Cancer
- (2015) C. Kratochwil et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Evaluation of 86Y-Labeled Inhibitors of Prostate-Specific Membrane Antigen for Dosimetry Estimates
- (2015) S. R. Banerjee et al. JOURNAL OF NUCLEAR MEDICINE
- Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen
- (2015) A. P. Kiess et al. JOURNAL OF NUCLEAR MEDICINE
- Biodistribution and Radiation Dosimetry for a Probe Targeting Prostate-Specific Membrane Antigen for Imaging and Therapy
- (2015) K. Herrmann et al. JOURNAL OF NUCLEAR MEDICINE
- The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions
- (2015) A. Afshar-Oromieh et al. JOURNAL OF NUCLEAR MEDICINE
- Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer
- (2015) M. Bene ova et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies
- (2015) M. Weineisen et al. JOURNAL OF NUCLEAR MEDICINE
- Comparison of [18F]DCFPyL and [68Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer
- (2015) Markus Dietlein et al. MOLECULAR IMAGING AND BIOLOGY
- Initial Evaluation of [18F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer
- (2015) Zsolt Szabo et al. MOLECULAR IMAGING AND BIOLOGY
- Vintafolide: a novel targeted therapy for the treatment of folate receptor expressing tumors
- (2015) Ignace Vergote et al. Therapeutic Advances in Medical Oncology
- Indium 111-labeled J591 anti-PSMA antibody for vascular targeted imaging in progressive solid tumors
- (2015) Neeta Pandit-Taskar et al. EJNMMI Research
- [111In]PSMA-I&T: expanding the spectrum of PSMA-I&T applications towards SPECT and radioguided surgery
- (2015) Margret Schottelius et al. EJNMMI Research
- Early side effects and first results of radioligand therapy with 177Lu-DKFZ-617 PSMA of castrate-resistant metastatic prostate cancer: a two-centre study
- (2015) Hojjat Ahmadzadehfar et al. EJNMMI Research
- (R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors
- (2015) Eleni Gourni et al. PLoS One
- Combination of the PI3K Inhibitor ZSTK474 with a PSMA-Targeted Immunotoxin Accelerates Apoptosis and Regression of Prostate Cancer
- (2015) Daniele Baiz et al. NEOPLASIA
- Ado-trastuzumab Emtansine
- (2014) Patricia A. Corrigan et al. ANNALS OF PHARMACOTHERAPY
- Prostate specific membrane antigen (PSMA) expression in primary gliomas and breast cancer brain metastases
- (2014) Natsuko Nomura et al. Cancer Cell International
- Radiation dosimetry and first therapy results with a 124I/131I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy
- (2014) Christian M. Zechmann et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The diagnostic value of PET/CT imaging with the 68Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer
- (2014) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 64Cu-Labeled Inhibitors of Prostate-Specific Membrane Antigen for PET Imaging of Prostate Cancer
- (2014) Sangeeta Ray Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen: Pharmacokinetics and Biodistribution Studies in Healthy Subjects and Patients with Metastatic Prostate Cancer
- (2014) S. Vallabhajosula et al. JOURNAL OF NUCLEAR MEDICINE
- Photoimmunotherapy Targeting Prostate-Specific Membrane Antigen: Are Antibody Fragments as Effective as Antibodies?
- (2014) R. Watanabe et al. JOURNAL OF NUCLEAR MEDICINE
- Development of Targeted Near-Infrared Imaging Agents for Prostate Cancer
- (2014) X. Wang et al. MOLECULAR CANCER THERAPEUTICS
- BAY 1075553 PET-CT for Staging and Restaging Prostate Cancer Patients: Comparison with [18F] Fluorocholine PET-CT (Phase I Study)
- (2014) Mohsen Beheshti et al. MOLECULAR IMAGING AND BIOLOGY
- Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer
- (2014) Rajendra Prasad Bandari et al. NUCLEAR MEDICINE AND BIOLOGY
- Efficacy studies of an antibody-drug conjugate PSMA-ADC in patient-derived prostate cancer xenografts
- (2014) Vincent A. DiPippo et al. PROSTATE
- Design and preclinical evaluation of a 99mTc-labelled diabody of mAb J591 for SPECT imaging of prostate-specific membrane antigen (PSMA)
- (2014) Florian Kampmeier et al. EJNMMI Research
- Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer
- (2014) Martina Weineisen et al. EJNMMI Research
- Prostate-specific membrane antigen expression in tumor-associated vasculature of breast cancers
- (2013) Alla Gabriella Wernicke et al. APMIS
- Preclinical evaluation of BAY 1075553, a novel 18F-labelled inhibitor of prostate-specific membrane antigen for PET imaging of prostate cancer
- (2013) Ralf Lesche et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Comparison of PET imaging with a 68Ga-labelled PSMA ligand and 18F-choline-based PET/CT for the diagnosis of recurrent prostate cancer
- (2013) Ali Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Effect of Chelators on the Pharmacokinetics of 99mTc-Labeled Imaging Agents for the Prostate-Specific Membrane Antigen (PSMA)
- (2013) Sangeeta Ray Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Preparation of Asymmetric Urea Derivatives that Target Prostate-Specific Membrane Antigen for SPECT Imaging
- (2013) Naoya Harada et al. JOURNAL OF MEDICINAL CHEMISTRY
- First-in-Man Evaluation of 2 High-Affinity PSMA-Avid Small Molecules for Imaging Prostate Cancer
- (2013) J. A. Barrett et al. JOURNAL OF NUCLEAR MEDICINE
- 99mTc-Labeled Small-Molecule Inhibitors of Prostate-Specific Membrane Antigen for Molecular Imaging of Prostate Cancer
- (2013) S. M. Hillier et al. JOURNAL OF NUCLEAR MEDICINE
- The prostate-specific membrane antigen: Lessons and current clinical implications from 20 years of research
- (2013) Benjamin T. Ristau et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Comparison of Gallium-68 and Fluorine-18 imaging characteristics in positron emission tomography
- (2012) Alejandro Sanchez-Crespo APPLIED RADIATION AND ISOTOPES
- 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging
- (2012) Matthias Eder et al. BIOCONJUGATE CHEMISTRY
- Synthesis and SAR of 99mTc/Re-labeled small molecule prostate specific membrane antigen inhibitors with novel polar chelates
- (2012) Genliang Lu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time
- (2012) Lindsey Chudley et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- [68Ga]Gallium-labelled PSMA ligand as superior PET tracer for the diagnosis of prostate cancer: comparison with 18F-FECH
- (2012) A. Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions
- (2012) A. Afshar-Oromieh et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Advances in Immuno–Positron Emission Tomography: Antibodies for Molecular Imaging in Oncology
- (2012) Scott M. Knowles et al. JOURNAL OF CLINICAL ONCOLOGY
- High expression of prostate-specific membrane antigen in the tumor-associated neo-vasculature is associated with worse prognosis in squamous cell carcinoma of the oral cavity
- (2012) Michael C Haffner et al. MODERN PATHOLOGY
- PSMA-targeted SPECT agents: Mode of binding effect on in vitro performance
- (2012) Jessie R. Nedrow-Byers et al. PROSTATE
- An Anti-PSMA Bivalent Immunotoxin Exhibits Specificity and Efficacy for Prostate Cancer Imaging and Therapy
- (2012) Fayun Zhang et al. Advanced Healthcare Materials
- A dimerized urea-based inhibitor of the prostate-specific membrane antigen for 68Ga-PET imaging of prostate cancer
- (2012) Martin Schäfer et al. EJNMMI Research
- Prostate-Specific Membrane Antigen as a Potential Novel Vascular Target for Treatment of Glioblastoma Multiforme
- (2011) A Gabriella Wernicke et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- Photodynamic therapy of cancer: An update
- (2011) Patrizia Agostinis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- 2-(3- -Ureido)-Pentanedioic Acid, [18F]DCFPyL, a PSMA-Based PET Imaging Agent for Prostate Cancer
- (2011) Y. Chen et al. CLINICAL CANCER RESEARCH
- Folate hydrolase (prostate-specific antigen) 1 expression in bladder cancer subtypes and associated tumor neovasculature
- (2011) Mary K Samplaski et al. MODERN PATHOLOGY
- A phosphoramidate-based prostate-specific membrane antigen-targeted SPECT agent
- (2011) Jessie R. Nedrow-Byers et al. PROSTATE
- A targeted low molecular weight near-infrared fluorescent probe for prostate cancer
- (2010) Tiancheng Liu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption
- (2010) Tiancheng Liu et al. CANCER LETTERS
- Preclinical Evaluation of a Recombinant Anti-Prostate Specific Membrane Antigen Single-Chain Immunotoxin Against Prostate Cancer
- (2010) Philipp Wolf et al. JOURNAL OF IMMUNOTHERAPY
- 68Ga-Labeled Inhibitors of Prostate-Specific Membrane Antigen (PSMA) for Imaging Prostate Cancer
- (2010) Sangeeta Ray Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure–activity relationship studies
- (2009) Haofan Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Preclinical Evaluation of Novel Glutamate-Urea-Lysine Analogues That Target Prostate-Specific Membrane Antigen as Molecular Imaging Pharmaceuticals for Prostate Cancer
- (2009) S. M. Hillier et al. CANCER RESEARCH
- Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers
- (2009) Michael C. Haffner et al. HUMAN PATHOLOGY
- Assessment of an 18F-Labeled Phosphoramidate Peptidomimetic as a New Prostate-Specific Membrane Antigen-Targeted Imaging Agent for Prostate Cancer
- (2009) S. E. Lapi et al. JOURNAL OF NUCLEAR MEDICINE
- Design, Synthesis, and Preclinical Evaluation of Prostate-Specific Membrane Antigen Targeted99mTc-Radioimaging Agents
- (2009) Sumith A. Kularatne et al. MOLECULAR PHARMACEUTICS
- In vitro targeted photodynamic therapy with a pyropheophorbide-a conjugated inhibitor of prostate-specific membrane antigen
- (2009) Tiancheng Liu et al. PROSTATE
- N-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-L-Cysteine, [18F]DCFBC: A New Imaging Probe for Prostate Cancer
- (2008) R. C. Mease et al. CLINICAL CANCER RESEARCH
- Synthesis and Evaluation of Technetium-99m- and Rhenium-Labeled Inhibitors of the Prostate-Specific Membrane Antigen (PSMA)
- (2008) Sangeeta R. Banerjee et al. JOURNAL OF MEDICINAL CHEMISTRY
- Radiohalogenated Prostate-Specific Membrane Antigen (PSMA)-Based Ureas as Imaging Agents for Prostate Cancer
- (2008) Ying Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Series of Halogenated Heterodimeric Inhibitors of Prostate Specific Membrane Antigen (PSMA) as Radiolabeled Probes for Targeting Prostate Cancer
- (2008) K. P. Maresca et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation